Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

NCT00088179 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4000

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: pexelizumab in conjunction with CABG

Sponsor

Alexion Pharmaceuticals, Inc.

Collaborators

[object Object]